Figure 3.
Figure 3. Kaplan-Meier estimates for DFS. armA, observation group; armB, azacitidine maintenance group. Azacitidine maintenance treatment increased the median DFS by 5.6 months (armA, 10.3 months; armB, 15.9 months).

Kaplan-Meier estimates for DFS. armA, observation group; armB, azacitidine maintenance group. Azacitidine maintenance treatment increased the median DFS by 5.6 months (armA, 10.3 months; armB, 15.9 months).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal